SK1452003A3 - Tartrate salts of thiazolidinedione derivative - Google Patents

Tartrate salts of thiazolidinedione derivative Download PDF

Info

Publication number
SK1452003A3
SK1452003A3 SK145-2003A SK1452003A SK1452003A3 SK 1452003 A3 SK1452003 A3 SK 1452003A3 SK 1452003 A SK1452003 A SK 1452003A SK 1452003 A3 SK1452003 A3 SK 1452003A3
Authority
SK
Slovakia
Prior art keywords
mesotartrate
solvate
compound
pyridyl
heat
Prior art date
Application number
SK145-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK1452003A3 publication Critical patent/SK1452003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
SK145-2003A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative SK1452003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (fr) 2000-08-04 2001-08-03 Sels de tartrate de derive de thiazolidinedione

Publications (1)

Publication Number Publication Date
SK1452003A3 true SK1452003A3 (en) 2004-05-04

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
SK145-2003A SK1452003A3 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Country Status (23)

Country Link
EP (1) EP1307448A1 (fr)
JP (1) JP2004505971A (fr)
KR (1) KR20030022356A (fr)
CN (1) CN1458930A (fr)
AP (1) AP2003002737A0 (fr)
AU (1) AU2001276508A1 (fr)
BG (1) BG107605A (fr)
BR (1) BR0112984A (fr)
CA (1) CA2417828A1 (fr)
CZ (1) CZ2003314A3 (fr)
EA (1) EA200300231A1 (fr)
EC (1) ECSP034468A (fr)
GB (1) GB0019226D0 (fr)
HU (1) HUP0300770A2 (fr)
IL (1) IL154277A0 (fr)
MA (1) MA25830A1 (fr)
MX (1) MXPA03001086A (fr)
NO (1) NO20030508L (fr)
OA (1) OA12355A (fr)
PL (1) PL360702A1 (fr)
SK (1) SK1452003A3 (fr)
WO (1) WO2002012233A1 (fr)
ZA (1) ZA200300962B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
OA12355A (en) 2004-03-19
WO2002012233A1 (fr) 2002-02-14
CA2417828A1 (fr) 2002-02-14
CN1458930A (zh) 2003-11-26
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
NO20030508L (no) 2003-03-20
NO20030508D0 (no) 2003-01-31
IL154277A0 (en) 2003-09-17
GB0019226D0 (en) 2000-09-27
EP1307448A1 (fr) 2003-05-07
MXPA03001086A (es) 2003-05-27
BR0112984A (pt) 2003-06-10
JP2004505971A (ja) 2004-02-26
KR20030022356A (ko) 2003-03-15
PL360702A1 (en) 2004-09-20
ZA200300962B (en) 2003-10-29
AP2003002737A0 (en) 2003-03-31
HUP0300770A2 (hu) 2003-11-28
MA25830A1 (fr) 2003-07-01
BG107605A (bg) 2003-09-30
CZ2003314A3 (cs) 2004-02-18

Similar Documents

Publication Publication Date Title
SK286399B6 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
SK1442003A3 (en) Tartrate salts of thiazolidinedione derivative
SK1452003A3 (en) Tartrate salts of thiazolidinedione derivative
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1462003A3 (en) Tartrate salt of thiazolidinedione derivative
SK2632003A3 (en) The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1432003A3 (en) Tartrate salts of thiazolidinedione derivative
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
AU2001292028A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
BG107678A (bg) Тиазолидиндионово производно и използването му като антидиабетично средство